PRE
$19.62-1.53 (-7.23%)
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution ...
Recent News
Prenetics Global CEO Touts IM8 Breakout Growth, Guides $180M-$200M Revenue at Conference
Prenetics Global (NASDAQ:PRE) CEO and co-founder Danny Yeung told investors the company delivered what he described as a “breakout growth story” in 2025, driven by the rapid expansion of its IM8 direct-to-consumer supplements business and a broader strategic shift to focus on that brand. 2025 perfo
Prenetics Global (PRE) Reports 480% Revenue Surge Driven by IM8 Brand Launch
Prenetics Global Limited (NASDAQ:PRE) is one of the most promising micro-cap stocks according to analysts. On February 18, Prenetics Global Limited reported financial results for 2025, headlined by a 480% year-over-year revenue surge to $92.4 million. This was fueled by the company’s flagship health and longevity brand, IM8, which reached an ARR of $120 million […]
Prenetics Global Limited Q4 2025 Earnings Call Summary
Moby summary of Prenetics Global Limited's Q4 2025 earnings call
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index decreasing 0
Prenetics Global Q4 Earnings Call Highlights
Prenetics Global (NASDAQ:PRE) used its fourth-quarter and full-year 2025 earnings call to detail what Chief Executive Officer and Co-founder Danny Yeung described as a “transformative” year, driven primarily by the launch of its premium consumer health brand IM8, which was co-founded with David Beck